Pentixapharm Holding AG (FRA:PTP)

Pentixapharm Holding AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024
Period Ending	Mar 31, 2025	Dec 31, 2024
Cash & Equivalents	17.39	23.23
Cash & Short-Term Investments	17.39	23.23
Accounts Receivable	0.02	6.81
Other Receivables	0.16	0.91
Receivables	0.18	7.71
Other Current Assets	2.19	0.34
Total Current Assets	19.76	31.28
Property, Plant & Equipment	0.27	0.27
Other Intangible Assets	35.02	35.35
Other Long-Term Assets	0.49	0.48
Total Assets	55.53	67.39
Accounts Payable	1.3	8.94
Accrued Expenses	-	0.6
Current Income Taxes Payable	-	0.08
Current Unearned Revenue	-	4.21
Other Current Liabilities	4.99	0.21
Total Current Liabilities	6.29	14.04
Long-Term Deferred Tax Liabilities	3.83	3.93
Other Long-Term Liabilities	0	0
Total Liabilities	10.13	17.97
Common Stock	24.8	24.8
Retained Earnings	-16.86	-12.84
Treasury Stock	-0.01	-0.01
Comprehensive Income & Other	37.48	37.48
Shareholders' Equity	45.4	49.42
Total Liabilities & Equity	55.53	67.39
Net Cash (Debt)	17.39	23.23
Net Cash Per Share	0.70	0.94
Filing Date Shares Outstanding	24.78	24.78
Total Common Shares Outstanding	24.78	24.78
Working Capital	13.47	17.24
Book Value Per Share	1.83	1.99
Tangible Book Value	10.39	14.06
Tangible Book Value Per Share	0.42	0.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.